The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in management based on actionable mutations in metastatic breast cancer in an ethnically diverse cohort: Single institution experience.
 
Sarah Premji
No Relationships to Disclose
 
Valentina Hoyos
No Relationships to Disclose
 
Shaun Bulsara
No Relationships to Disclose
 
Susan G. Hilsenbeck
No Relationships to Disclose
 
Maryam Nemati Shafaee
Research Funding - Mirati Therapeutics
 
Matthew James Ellis
Employment - Bioclassifier
Leadership - Bioclassifier
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - Foundation Medicine; G1 Therapeutics; Huron Consulting; Lilly; Novartis; Veracyte
Patents, Royalties, Other Intellectual Property - Patent on PAM50, which generates royalties on the license to Bioclassifier/Prosigna/Nanostring
 
C. Kent Osborne
Stock and Other Ownership Interests - Genentech
Honoraria - Genentech
Consulting or Advisory Role - Lilly; Tolmar
Patents, Royalties, Other Intellectual Property - Lippincott
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Daiichi Sankyo; Genentech; Macrogenics; Seagen
Research Funding - Pfizer (Inst)
 
Julie R. Nangia
Research Funding - Paxman